DNA methylation and B-cell autoreactivity

Advances in Experimental Medicine and Biology

Volumn 711, Issue , 2011, Pages 50-60

  Garaud, Soizic ^a   Youinou, Pierre ^a,b   Renaudineau, Yves ^a,b  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; B LYMPHOCYTE RECEPTOR; CD5 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; ISONIAZID; PROCAINAMIDE; TRANSCRIPTION FACTOR PAX5; CYTOKINE;

ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CPG ISLAND; CYTOKINE PRODUCTION; DEACETYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTONE MODIFICATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOREGULATION; INNATE IMMUNITY; ISOMERIZATION; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BIOSYNTHESIS; ENDOGENOUS RETROVIRUS; GENETICS; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

HUMAN ENDOGENOUS RETROVIRUS;

ANIMALS; ANTIGENS, CD5; B-LYMPHOCYTES; CYTOKINES; DNA METHYLATION; ENDOGENOUS RETROVIRUSES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 79958255801     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8216-2_5     Document Type: Article

References (41)

1. Rauch TA, Wu X, Zhong X et al. A human B-cell methylome at 100-base pair resolution. Proc Natl Acad Sci USA 2009; 106:671-8.
2. Dieker J, Muller S. Epigenetic histone code and autoimmunity. Clin Rev Allergy Immunol 2009; DOI: 10-1007/s12016-009-8173-7.
3. Sims GP, Ettinger R, Shirota Y et al. Identification and characterization of circulating human transitional B-cells. Blood 2005; 105:4390-8. (Pubitemid 40720786)
4. Decker T, Pasca di Magliano M, McManus S et al. M. Stepwise activation of enhancer and promoter regions of the B-cell commitment gene Pax5 in early lymphopoiesis. Immunity 2009; 30:508-20.
5. Renaudineau Y, Garaud S, Le Dantec C et al. Autoreactive B-cells and Epigenetics. ClinRev Allergy Immunol 2009; DOI: 10.1007/s12016-009-8174-6.
6. Sakano H, Maki R, Kurosawa Y et al. Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature 1980; 286:676-83. (Pubitemid 11247276)
7. Storb U, Arp B. Methylation patterns of immunoglobulin genes in lymphoid cells: correlation of expression and differentiation with undermethylation. Proc Natl Acad Sci USA 1983; 80:6642-6. (Pubitemid 14240151)
8. Xu CR, Feeney AJ. The epigenetic profile of Ig genes is dynamically regulated during B-cell differentiation and is modulated by pre-B-cell receptor signaling. J Immunol 2009; 182:1362-9.
9. Nakase H, Takahama Y, Akamatsu Y. Effect of CpG methylation on RAG1/RAG2 reactivity: implications of direct and indirect mechanisms for controlling V(D)J cleavage. EMBO 2003; 4:774-80. (Pubitemid 37063185)
10. Espinoza CR, Feeney AJ. Chromatin accessibility and epigenetic modifications differ between frequently and infrequently rearranging VH genes. Mol Immunol 2007; 44:2675-85. (Pubitemid 46240315)
11. Fujimura S, Matsui T, Kuwahara K et al. Germinal center B-cell-associated DNA hypomethylation at transcriptional regions of the AID gene. Mol Immunol 2008; 45:1712-9. (Pubitemid 351221133)
12. Larijani M, Frieder D, Sonbuchner TM et al. Methylation protects cytidines from AID-mediated deamination. Mol Immunol 2005; 42:599-604. (Pubitemid 39655938)
13. Harris DP, Haynes L, Sayles PC et al. Reciprocal regulation of polarized cytokine production by effector B and T-cells. Nat Immunol 2000; 1:475-82.
14. BowenH, Kelly A, Lee T et al. Control of cytokine gene transcription in Th1 and Th2 cells. Clin Exp Allergy 2008; 38:1422-31.
15. Youinou P, Renaudineau Y. The paradox of CD5-expressing B-cells in systemic lupus erythematosus. Autoimmun Rev 2007; 7:149-54. (Pubitemid 350116728)
16. QianY, Santiago C,BorreroM et al. Lupus-specific antiribonucleoproteinB- cell tolerance innonautoimmune mice is maintained by differentiation to B-1 and governed by B-cell receptor signaling thresholds. J Immunol 2001; 166:2412-9. (Pubitemid 32173476)
17. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B-cells. J Exp Med 2000; 191:883-8.
18. Hillion S, Rochas C, Youinou P et al. Expression and reexpression of recombination activating genes: relevance to the development of autoimmune states. Ann NY Acad Sci 2005; 1050:10-8. (Pubitemid 41129419)
19. Garaud S, Le Dantec C, de Mendoza AR et al. IL-10 production by B-cells expressing CD5 with the alternative exon 1B. Ann NY Acad Sci 2009; 1173:280-5.
20. Gunnarsson I, Nordmark B, Hassan Bakri A et al. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA. Rheumatology (Oxford) 2000; 39:886-93. (Pubitemid 30649517)
21. Fillatreau S, Sweenie CH, McGeachy MJ et al. B-cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3:944-50. (Pubitemid 35154008)
22. Renaudineau Y, Vallet S, Le Dantec C et al. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes. Genes Immun 2005; 6:663-71. (Pubitemid 41741711)
23. Renaudineau Y, Hillion S, Saraux A et al. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood 2005; 106:2781-9. (Pubitemid 41510754)
24. Garaud S, Le Dantec C, BerthouCet al. Selection ofthe alternative exon 1 from theCD5 gene down-regulates membrane level of the protein in B lymphocytes. J Immunol 2008; 181:2010-8.
25. Garaud S, Le Dantec C, Jousse-Joulin S et al. IL-6 modulates CD5 expression in B-cells from patients with lupus by regulating DNA methylation. J Immunol 2009; 182:5623-32.
26. Brooks WH, Le Dantec C, Pers JO et al. Epigenetics and autoimmunity. J Autoimmun 2010; 34:J207-19.
27. Cannat A, Seligmann M. Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin Exp Immunol 1968; 3:99-105.
28. Mazari L, Ouarzane M, Zouali M. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci U SA 2007; 104:6317-22. (Pubitemid 47186092)
29. Quddus J, Johnson KJ, Gavalchin J et al. Treating activated CD4+ T-cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92:38-53. (Pubitemid 23208979)
30. Javierre BM, Fernandez AF, Richter J et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010; 20:170-9.
31. Zhao S, Long H, Lu Q. Epigenetic perspectives in systemic lupus erythematosus: Pathogenesis, biomarkers and therapeutic potentials. Clin Rev Allergy Immunol 2009; DOI:10-1007/s12016-009-8165-7.
32. Gorelik G, Fang JY, Wu A et al. Impaired T-cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 2007; 179:5553-63.
33. Miyamoto A, Nakayama K, Imaki H et al. Increased proliferation of B-cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002; 416:865-9. (Pubitemid 34453744)
34. Youinou P, Jamin C. The weight of interleukin-6 in B-cell-related autoimmune disorders. J Autoimmun 2009; 32:206-10.
35. Liang B, Gardner DB, Griswold DE et al. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology 2006; 119:296-305. (Pubitemid 44571047)
36. Hillion S, Garaud S, Devauchelle V et al. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus. Immunology 2007; 122:371-80. (Pubitemid 47556474)
37. Brown SE, Fraga MF, Weaver IC et al. Variations in DNA methylation patterns during the cell cycle of HeLa cells. Epigenetics 2007; 2:54-65. (Pubitemid 46830295)
38. Dandrea M, Donadelli M, Costanzo C et al. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Res 2009; 37:6681-90.
39. Mi XB, Zeng FQ. Hypomethylation of interleukin-4 and -6 promoters in T-cells from systemic lupus erythematosus patients. Acta Pharmacol Sin 2008; 29:105-12.
40. BlancoBetancourt CE, Moncla A, Milili M et al. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood 2004; 103:2683-90. (Pubitemid 38393025)
41. Renaudineau Y. The Revolution of Epigenetics in the Field of Autoimmunity. Clin Rev Allergy Immunol 2009; DOI: 10-1007/s12016-009-8171-9.